Insider Trading Activity Radius Health, Inc. (NASDAQ:RDUS) – Major Shareholder Bought 60,000 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Radius Health, Inc. (NASDAQ:RDUS)

Growth N V Biotech , Major Shareholder of Radius Health, Inc. (NASDAQ:RDUS) reportedly Bought 60,000 shares of the company’s stock at an average price of 35.98 for a total transaction amount of $2,158,800.00 SEC Form

Insider Trading History For Radius Health, Inc. (NASDAQ:RDUS)

On 6/6/2014 Growth N V Biotech, Major Shareholder, bought 1,000,000 with an average share price of $8.00 per share and the total transaction amounting to $8,000,000.00.View SEC Filing

On 6/11/2014 Morana Jovan-Embiricos, Director, bought 587,500 with an average share price of $8.00 per share and the total transaction amounting to $4,700,000.00.View SEC Filing

On 2/25/2015 Growth N V Biotech, Major Shareholder, bought 35,000 with an average share price of $45.74 per share and the total transaction amounting to $1,600,900.00.View SEC Filing

On 3/6/2015 Growth N V Biotech, Major Shareholder, bought 75,000 with an average share price of $47.08 per share and the total transaction amounting to $3,531,000.00.View SEC Filing

On 4/27/2015 Growth N V Biotech, Major Shareholder, bought 50,000 with an average share price of $38.38 per share and the total transaction amounting to $1,919,000.00.View SEC Filing

On 4/28/2015 Growth N V Biotech, Major Shareholder, bought 50,000 with an average share price of $36.59 per share and the total transaction amounting to $1,829,500.00.View SEC Filing

On 4/29/2015 Growth N V Biotech, Major Shareholder, bought 50,000 with an average share price of $36.23 per share and the total transaction amounting to $1,811,500.00.View SEC Filing

Analyst Ratings For Radius Health, Inc. (NASDAQ:RDUS)
These are 1 Sell Rating, 2 Hold Ratings, 4 Buy Ratings .
The current consensus rating for Radius Health, Inc. (NASDAQ:RDUS) is Hold (Score: 2.43) with a consensus target price of $53.60 , a potential (50.90% upside)

Analyst Ratings History For Radius Health, Inc. (NASDAQ:RDUS)

On 1/25/2016 Bank of America Corporation Reiterated Rating Buy with a price target of $89.00
On 3/30/2016 Goldman Sachs Group, Inc. (The) Initiated Coverage of rating Neutral with a price target of $37.00
On 3/11/2017 J P Morgan Chase & Co Reiterated Rating Buy
On 5/2/2017 Cowen and Company Downgraded rating Outperform to Market Perform
On 5/15/2017 HC Wainwright Reiterated Rating Buy with a price target of $63.00
On 5/24/2017 Maxim Group Set Price Target of rating Sell with a price target of $24.00
On 7/23/2017 Cantor Fitzgerald Set Price Target of rating Buy with a price target of $58.00

Recent Trading Activity for Radius Health, Inc. (NASDAQ:RDUS)
Shares of Radius Health, Inc. closed the previous trading session at 35.52 up +0.10 0.28% with 793,696 shares trading hands.